H.R. 7601: No Immunity for Glyphosate Act

The 'No Immunity for Glyphosate Act' (H.R. 7601) is a bipartisan bill introduced on February 20, 2026, by Representative Thomas Massie (R-KY) and co-sponsored by several other members of Congress. The bill aims to: 1) Prohibit the use of federal funds to implement the Executive Order titled 'Promoting the National Defense by Ensuring an Adequate Supply of Elemental Phosphorus and Glyphosate-Based Herbicides,' issued on February 18, 2026. This Executive Order had invoked the Defense Production Act to prioritize domestic production of these chemicals and provided liability protections to manufacturers. 2) Establish a federal cause of action allowing individuals who have suffered physical injury, illness, disease, or death due to exposure to elemental phosphorus or glyphosate-based herbicides to file civil lawsuits against manufacturers, distributors, and suppliers. The bill removes certain legal immunities and defenses that companies might otherwise use to avoid liability, ensuring that affected individuals retain their right to seek remedies in court. The bill has been referred to the House Committee on the Judiciary for further consideration.

Supporters of the 'No Immunity for Glyphosate Act' argue that it holds chemical manufacturers accountable and prevents the government from using national security as a means to shield these companies from responsibility. Representative Thomas Massie stated, 'Congress should ensure that Americans retain their right to seek a remedy in court if they believe they have been injured by this product.' The bill has received endorsements from organizations like the Farm Action Fund, which advocates for fair practices in agriculture. Proponents believe that by removing legal immunities, the legislation empowers individuals to seek compensation for health issues linked to glyphosate exposure and promotes corporate responsibility.

Critics of the 'No Immunity for Glyphosate Act' express concerns that the increased potential for lawsuits could discourage the production of glyphosate-based herbicides, which are widely used by farmers for weed control. They argue that this could lead to higher costs for agricultural operations and impact food production. Additionally, some industry representatives contend that glyphosate has been deemed safe when used properly by certain regulatory agencies, and that the bill could undermine the availability of essential agricultural chemicals. There is also apprehension that the legislation might create a complex legal environment for the agricultural and defense industries, potentially leading to financial and operational challenges.

The primary potential conflict of interest lies in the overlap between the sponsor's top donor industry, Health Professionals, and the subject matter of the bill, Health. Health Professionals have donated a substantial amount of $240,000,000 to the sponsor, Thomas Massie. This could potentially influence the sponsor's decision-making process regarding the bill, as he may be inclined to favor the interests of his donors. However, it is important to note that this is only a potential conflict and not a definitive one. The lobbying activity in this bill's policy area is also worth noting. Various organizations have been lobbying, with disclosed amounts ranging from $10,000 to $70,000. This lobbying activity could potentially influence the outcome of the bill. Voters should be aware of these potential conflicts of interest when considering the implications of this bill.

These industries are both affected by this bill and among the sponsor's top donors.

Organizations that lobbied on issues related to this bill's policy area.

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Top industries funding Thomas Massie, ranked by total contributions.

Source: OpenSecrets.org (Center for Responsive Politics)